Quest Diagnostics (DGX) Tax Provisions (2009 - 2026)

Quest Diagnostics (DGX) has 18 years of Tax Provisions data on file, last reported at $74.0 million in Q1 2026.

• Quarterly Tax Provisions rose 25.42% year-over-year to $74.0 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $329.0 million (up 23.68% YoY) and the FY2025 annual result came in at $314.0 million, up 15.02% from the prior year.
• Tax Provisions fell to $74.0 million in Q1 2026 per DGX's latest filing, from $81.0 million in the prior quarter.
• The five-year high for Tax Provisions was $110.0 million in Q1 2022, with the low at -$4.0 million in Q4 2022.
• Average Tax Provisions over 5 years is $69.0 million, with a median of $74.0 million recorded in 2024.
• Year-over-year, Tax Provisions slumped 103.51% in 2022 and jumped 1100.0% in 2023.
• Quest Diagnostics' Tax Provisions stood at -$4.0 million in 2022, then jumped by 1100.0% to $40.0 million in 2023, then soared by 70.0% to $68.0 million in 2024, then gained by 19.12% to $81.0 million in 2025, then declined by 8.64% to $74.0 million in 2026.
• Business Quant data shows DGX's Tax Provisions at $74.0 million in Q1 2026, $81.0 million in Q4 2025, and $77.0 million in Q3 2025.